Literature DB >> 9160893

Astrocytic adhesion molecules are increased in HIV-1-associated cognitive/motor complex.

D Seilhean1, A Dzia-Lepfoundzou, V Sazdovitch, B Cannella, C S Raine, C Katlama, F Bricaire, C Duyckaerts, J J Hauw.   

Abstract

Half of AIDS dementia cases are associated with HIV-encephalitis or myelin pallor. Another half die with no HIV-related neuropathological changes. Previous observations suggest that cerebral dysfunction may result from more subtle cellular interactions. and that some of them may be mediated by cell adhesion molecules. In the present study the expression by astrocytes and endothelial cells of intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) was analysed as a function of the neuropathological diagnosis, the density of astrogliosis and of HIV-1 positive cells, and of the mental status. Twelve AIDS cases, without focal brain lesion, eight of whom were demented, were selected from a prospective study. They were compared with six control cases with multiple sclerosis, and with six control patients without neurological disease. ICAM-1 and VCAM-1 expression was localized by immunofluorescence and confocal microscopy. HIV protein gp41 was detected by immunohistochemistry on adjacent sections. Endothelial expression of ICAM-1 and VCAM-1 was significantly up-regulated in all AIDS patients. VCAM-1 only was related to myelin pallor. The density of VCAM-1 or ICAM-1 positive astrocytes increased in demented AIDS patients, independently of the neuropathological findings or the density of gp41 positive cells. Expression of cell adhesion molecules, together with other secondary mechanisms such as secretion of cytokines may play a role in the pathogenesis of white matter lesions leading to HIV-1-associated cognitive changes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160893

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  10 in total

1.  Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS.

Authors:  E A Eugenin; R Gamss; C Buckner; D Buono; R S Klein; E E Schoenbaum; T M Calderon; J W Berman
Journal:  J Leukoc Biol       Date:  2006-01-13       Impact factor: 4.962

2.  Role of retinal vascular endothelial cells in development of CMV retinitis.

Authors:  N A Rao; J Zhang; S Ishimoto
Journal:  Trans Am Ophthalmol Soc       Date:  1998

Review 3.  Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.

Authors:  Suzi Hong; William A Banks
Journal:  Brain Behav Immun       Date:  2014-10-22       Impact factor: 7.217

4.  Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia.

Authors:  Malcolm J Avison; Avindra Nath; Robin Greene-Avison; Frederick A Schmitt; Rodney A Bales; As'ad Ethisham; Richard N Greenberg; Joseph R Berger
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

Review 5.  Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.

Authors:  Catherine DeMarino; Angela Schwab; Michelle Pleet; Allison Mathiesen; Joel Friedman; Nazira El-Hage; Fatah Kashanchi
Journal:  J Neuroimmune Pharmacol       Date:  2016-07-02       Impact factor: 4.147

Review 6.  Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.

Authors:  Clarisa M Buckner; Aimée J Luers; Tina M Calderon; Eliseo A Eugenin; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2006-04-13       Impact factor: 4.147

Review 7.  Mechanism(s) involved in opioid drug abuse modulation of HAND.

Authors:  Raini Dutta; Sabita Roy
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

8.  Altered expression of fractalkine in HIV-1-infected astrocytes and consequences for the virus-related neurotoxicity.

Authors:  Vincent Sénécal; Corinne Barat; Marie-Thérèse Gagnon; François Vanasse; Mathieu Leboeuf; David Gosselin; Michel J Tremblay
Journal:  J Neurovirol       Date:  2021-03-01       Impact factor: 2.643

9.  Novel mechanisms of central nervous system damage in HIV infection.

Authors:  Joy E Hazleton; Joan W Berman; Eliseo A Eugenin
Journal:  HIV AIDS (Auckl)       Date:  2010-03-11

10.  Inflammatory mediators reduce surface PrPc on human BMVEC resulting in decreased barrier integrity.

Authors:  Bezawit W Megra; Eliseo A Eugenin; Joan W Berman
Journal:  Lab Invest       Date:  2018-06-29       Impact factor: 5.662

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.